advertisement

		Poll Results	Jump to a new section --[ Getting Around ]-- Home Page What's New Privacy Policy Search --[ People ]-- Family Support Network Adults with Diabetes Care Photos Chat Rooms Conferences Kids with Diabetes Parents Parent Humor Scholarships and Financial Aid Grandparents Humorous Tidbits Jobs Mailing Lists CWD Forums Poetry and Art Videos Polls Quilt for Life Surveys Blogs --[ Clinic ]-- Ask the Diabetes Team Alternate Site Testing Alternative Treatments Care Suggestions CWD Español Diabetes Basics Diabetes at School 504 Plans Diabetes Camps Diabetes Dictionary Insulin Pumps Nutrition Podcasts Presentations Products Product Marketplace Sports Studies Warning Signs --[ Sources ]-- News and Information Diabetes Advocacy Links to Other Web Sites Press Releases Regional Information Services Support Groups --[ Feedback ]-- About CWD Advertise Awards Contribute Your Experiences Disclaimer Letters to the Editor Logos and Linking Share our Brochures

Poll Results   Which insulins do you or your child use?     Vote for all that apply     Short acting insulins         NovoLog/Novorapid     35%     248         Humalog     19%     136         Apidra     1%     13         Regular / Actrapid / Velosulin     1%     10         Other short acting insulin     1%     1     Long acting insulins         Lantus     30%     212         Levemir     4%     29         NPH / Isophane / Insulatard     3%     27         Lente     0%      0         Ultralente     1%     1         Other long acting insulin     1%     3     Other         Premixed (70/30, etc.)     1%     7         Other insulin     0%      0         Don't use insulin     1%     3   Total votes: 690

Which insulins do you or your child use? Poll dates: January 20 - 27, 2008 Total Votes: 690 Insulin users today have a great variety of products from which to choose. In the past few years, two fast-acting analogs (NovoLog and Humalog) and one long-acting analog (Lantus) have been introduced and have changed the way many people use insulin. The use of Regular insulin among our readers has dropped off to just one percent. NPH use has dropped too, from 32% in 2000 to just 3% in 2008. This table shows readers' answers to this survey over the past years:   Answer     Jan 2008     Jan 2007     Jan 2006     Jan 2005     Jan 2004     Jan 2003     Jan 2002     Mar 2000   Short acting insulins NovoLog 35% 33% 28% 27% 26% 12% 3% -- Humalog 19% 17% 20% 22% 26% 34% 37% 35% Regular 1% 1% 1% 1% 2% 3% 4% 12% Apidra 1% 1% 1% 1% -- -- -- -- Long acting insulins Lantus 30% 31% 32% 27% 21% 17% 11% -- Levemir 4% 4% 2% 1% -- -- -- -- NPH 3% 6% 8% 14% 16% 22% 28% 32% Lente 0% 1% 1% 1% 1% 1% 3% 4% Ultralente 1% 1% 1% 1% 1% 2% 5% 7% Other Premixed 1% 1% 1% 1% 1% 2% 2% 5% Other insulin 2% 1% 1% 1% 1% 2% 2% 2% Percentages based on use compared with all responses Looking at answers in the short-acting and long-acting insulins shows a dramatic change since 2000. The following graphs illustrate the rapid increase in use of insulin analogs and the concurrent decline in the use of Regular and NPH. Rapid Acting Insulin Use The rise in the use of NovoLog has been particularly significant since it was introduced in 2002. Among users of rapid-acting insulin, NovoLog is used by almost two-thirds of our visitors (61%), while use of Humalog has stabilized at about one-third (33%). Apidra, new to the US market in 2006, now has 3% of rapid acting insulin uses. The use of Regular continues to decline. Data within rapid-acting insulin only illustrating the steady increase in the use of NovoLog Data for rapid-acting insulin among all responses Long Acting Insulin Use As of January 2008, more CWD visitors report using Lantus than any other long acting insulin by a wide margin. This year, 79% of people who use long acting insulin report using Lantus. The use of NPH continues to decline and and now stands at just 10% for people who use long acting insulin. Lente is gone, and just one person reported using Ultralente. Levemir, new in 2005, is used by 11%. Given the clinical benefits of using Lantus or Levemir over NPH, it's no surprise to see the rapid decline in use of NPH. (See our page about Care Suggestions for citations to studies about NPH.) Data for long-acting insulin only showing the continuing decline in the use of NPH insulin Data for long-acting insulin among all responses [Download an Excel spreadsheet with the data and graphs from this poll] [Return to the current poll]

		Not Helpful  1 2 3 4 5  Very Helpful                  E-mail Page     Print Format
			Jump to a new section --[ Getting Around ]-- Home Page What's New Privacy Policy Search --[ People ]-- Family Support Network Adults with Diabetes Care Photos Chat Rooms Conferences Kids with Diabetes Parents Parent Humor Scholarships and Financial Aid Grandparents Humorous Tidbits Jobs Mailing Lists CWD Forums Poetry and Art Videos Polls Quilt for Life Surveys Blogs --[ Clinic ]-- Ask the Diabetes Team Alternate Site Testing Alternative Treatments Care Suggestions CWD Español Diabetes Basics Diabetes at School 504 Plans Diabetes Camps Diabetes Dictionary Insulin Pumps Nutrition Podcasts Presentations Products Product Marketplace Sports Studies Warning Signs --[ Sources ]-- News and Information Diabetes Advocacy Links to Other Web Sites Press Releases Regional Information Services Support Groups --[ Feedback ]-- About CWD Advertise Awards Contribute Your Experiences Disclaimer Letters to the Editor Logos and Linking Share our Brochures

Last Updated: Sunday January 27, 2008 13:53:33
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.